{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T08:57:15Z","timestamp":1790758635435,"version":"4.1.0"},"reference-count":88,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2019,6,6]],"date-time":"2019-06-06T00:00:00Z","timestamp":1559779200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2019,6,6]],"date-time":"2019-06-06T00:00:00Z","timestamp":1559779200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100000838","name":"University of Sussex","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100000838","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur Radiol"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1007\/s00330-019-06166-z","type":"journal-article","created":{"date-parts":[[2019,6,6]],"date-time":"2019-06-06T11:03:21Z","timestamp":1559819001000},"page":"6940-6952","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":76,"title":["The primacy of multiparametric MRI in men with suspected prostate cancer"],"prefix":"10.1007","volume":"29","author":[{"given":"Jonathan","family":"Richenberg","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vibeke","family":"L\u00f8gager","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valeria","family":"Panebianco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Rouviere","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geert","family":"Villeirs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivo G.","family":"Schoots","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,6,6]]},"reference":[{"issue":"4","key":"6166_CR1","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1007\/s00330-011-2377-y","volume":"22","author":"Jelle O. Barentsz","year":"2012","unstructured":"Barentsz JO, Richenberg J, Clements R et al (2012) ESUR prostate MR guidelines 2012. Eur Radiol. \nhttps:\/\/doi.org\/10.1007\/s00330-011-2377-y","journal-title":"European Radiology"},{"key":"6166_CR2","unstructured":"Mottet N, van den Bergh RCN, Briers E et al (2018) Guidelines on prostate cancer. \nhttps:\/\/uroweb.org\/guideline\/prostate-cancer\/?type=archive"},{"key":"6166_CR3","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1001\/jama.280.11.969","volume":"280","author":"AV D\u2019Amico","year":"1998","unstructured":"D\u2019Amico AV, Whittington R, Malkowicz SB et al (1998) Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer. JAMA 280:969\u2013974","journal-title":"JAMA"},{"key":"6166_CR4","doi-asserted-by":"publisher","first-page":"3726","DOI":"10.1200\/JCO.2004.01.164","volume":"22","author":"AV D'Amico","year":"2004","unstructured":"D'Amico AV, Renshaw AA, Cote K et al (2004) Impact of the percentage of positive prostate cores on prostate cancer-specific mortality for patients with low or favorable intermediate-risk disease. J Clin Oncol 22:3726\u20133732","journal-title":"J Clin Oncol"},{"key":"6166_CR5","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1016\/S0090-4295(01)01665-X","volume":"59","author":"PW Linson","year":"2002","unstructured":"Linson PW, Lee AK, Doytchinova T et al (2002) Percentage of core lengths involved with prostate cancer: does it add to the percentage of positive prostate biopsies in predicting postoperative prostate-specific antigen outcome for men with intermediate-risk prostate cancer. Urology 59:704\u2013708","journal-title":"Urology"},{"key":"6166_CR6","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1016\/S0090-4295(02)02525-6","volume":"61","author":"SJ Freedland","year":"2003","unstructured":"Freedland SJ, Aronson WJ, Csathy GS et al (2003) Comparison of percentage of total prostate needle biopsy tissue with cancer to percentage of cores with cancer for predicting PSA recurrence after radical prostatectomy: results from the SEARCH database. Urology 61:742\u2013747","journal-title":"Urology"},{"key":"6166_CR7","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1016\/j.juro.2014.02.005","volume":"192","author":"JC Hu","year":"2014","unstructured":"Hu JC, Chang E, Natarajan S et al (2014) Targeted prostate biopsy in select men for active surveillance: do the Epstein criteria still apply? J Urol 192:385\u2013390","journal-title":"J Urol"},{"key":"6166_CR8","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1016\/j.juro.2009.10.046","volume":"183","author":"JI Epstein","year":"2010","unstructured":"Epstein JI (2010) An update of the Gleason grading system. J Urol 183:433\u2013440","journal-title":"J Urol"},{"key":"6166_CR9","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1016\/j.eururo.2015.01.013","volume":"68","author":"JJ F\u00fctterer","year":"2015","unstructured":"F\u00fctterer JJ, Briganti A, De Visschere P et al (2015) Can clinically significant prostate cancer be detected with multiparametric magnetic resonance imaging? A systematic review of the literature. Eur Urol 68:1045\u20131053","journal-title":"Eur Urol"},{"key":"6166_CR10","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1016\/j.eururo.2015.06.046","volume":"69","author":"JI Epstein","year":"2016","unstructured":"Epstein JI, Zelefsky MJ, Sjoberg DD et al (2016) A contemporary prostate cancer grading system: a validated alternative to the Gleason score. Eur Urol 69:428\u2013435","journal-title":"Eur Urol"},{"key":"6166_CR11","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1158\/1055-9965.EPI-16-0434","volume":"26","author":"R Gulati","year":"2017","unstructured":"Gulati R, Cheng HH, Lange PH, Nelson PS, Etzioni R (2017) Screening men at increased risk for prostate Cancer diagnosis: model estimates of benefits and harms. Cancer Epidemiol Biomarkers Prev 26:222\u2013227","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"6166_CR12","doi-asserted-by":"publisher","first-page":"2019","DOI":"10.1007\/s00330-013-2795-0","volume":"23","author":"F Bratan","year":"2013","unstructured":"Bratan F, Niaf E, Melodelima C et al (2013) Influence of imaging and histological factors on prostate cancer detection and localisation on multiparametric MRI: a prospective study. Eur Radiol 23:2019\u20132029","journal-title":"Eur Radiol"},{"key":"6166_CR13","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1097\/RLI.0b013e318263f0fd","volume":"47","author":"KM Selnaes","year":"2012","unstructured":"Selnaes KM, Heerschap A, Jensen LR et al (2012) Peripheral zone prostate cancer localization by multiparametric magnetic resonance at 3 T: unbiased cancer identification by matching to histopathology. Invest Radiol 47:624\u2013633","journal-title":"Invest Radiol"},{"key":"6166_CR14","doi-asserted-by":"publisher","first-page":"1818","DOI":"10.1016\/j.juro.2011.07.013","volume":"186","author":"B Turkbey","year":"2011","unstructured":"Turkbey B, Mani H, Shah V et al (2011) Multiparametric 3T prostate magnetic resonance imaging to detect cancer: histopathological correlation using prostatectomy specimens processed in customized magnetic resonance imaging based molds. J Urol 186:1818\u20131824","journal-title":"J Urol"},{"key":"6166_CR15","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1016\/j.eururo.2014.08.079","volume":"67","author":"JD Le","year":"2015","unstructured":"Le JD, Tan N, Shkolyar E et al (2015) Multifocality and prostate cancer detection by multiparametric magnetic resonance imaging: correlation with whole-mount histopathology. Eur Urol 67:569\u2013576","journal-title":"Eur Urol"},{"key":"6166_CR16","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.eururo.2011.08.042","volume":"61","author":"T Hambrock","year":"2012","unstructured":"Hambrock T, Hoeks C, Hulsbergen-van de Kaa C et al (2012) Prospective assessment of prostate cancer aggressiveness using 3-T diffusion-weighted magnetic resonance imaging-guided biopsies versus a systematic 10-core transrectal ultrasound prostate biopsy cohort. Eur Urol 61:177\u2013184","journal-title":"Eur Urol"},{"key":"6166_CR17","doi-asserted-by":"publisher","first-page":"1074","DOI":"10.1016\/j.eururo.2011.03.002","volume":"60","author":"T Kobus","year":"2011","unstructured":"Kobus T, Hambrock T, Hulsbergen-van de Kaa CA et al (2011) In vivo assessment of prostate cancer aggressiveness using magnetic resonance spectroscopic imaging at 3 T with an endorectal coil. Eur Urol 60:1074\u20131080","journal-title":"Eur Urol"},{"key":"6166_CR18","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1148\/radiol.2461070057","volume":"246","author":"L Wang","year":"2008","unstructured":"Wang L, Mazaheri Y, Zhang J, Ishill NM, Kuroiwa K, Hricak H (2008) Assessment of biologic aggressiveness of prostate cancer: correlation of MR signal intensity with Gleason grade after radical prostatectomy. Radiology 246:168\u2013176","journal-title":"Radiology"},{"key":"6166_CR19","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1148\/radiol.14140524","volume":"275","author":"F Bratan","year":"2015","unstructured":"Bratan F, Melodelima C, Souchon R et al (2015) How accurate is multiparametric MR imaging in evaluation of prostate cancer volume. Radiology 275:144\u2013154","journal-title":"Radiology"},{"key":"6166_CR20","doi-asserted-by":"publisher","first-page":"351","DOI":"10.2214\/AJR.18.20147","volume":"212","author":"C Sun","year":"2019","unstructured":"Sun C, Chatterjee A, Yousuf A et al (2019) Comparison of T2-weighted imaging, DWI, and dynamic contrast-enhanced MRI for calculation of prostate cancer index lesion volume: correlation with whole-mount pathology. AJR Am J Roentgenol 212:351\u2013356","journal-title":"AJR Am J Roentgenol"},{"key":"6166_CR21","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.eururo.2015.08.052","volume":"69","author":"JC Weinreb","year":"2016","unstructured":"Weinreb JC, Barentsz JO, Choyke PL et al (2016) PI-RADS prostate imaging - reporting and data system: 2015, version 2. Eur Urol 69:16\u201340","journal-title":"Eur Urol"},{"key":"6166_CR22","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.eururo.2015.08.038","volume":"69","author":"JO Barentsz","year":"2016","unstructured":"Barentsz JO, Weinreb JC, Verma S et al (2016) Synopsis of the PI-RADS v2 guidelines for multiparametric prostate magnetic resonance imaging and recommendations for use. Eur Urol 69:41\u201349","journal-title":"Eur Urol"},{"key":"6166_CR23","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.eururo.2017.01.042","volume":"72","author":"S Woo","year":"2017","unstructured":"Woo S, Suh CH, Kim SY, Cho JY, Kim SH (2017) Diagnostic performance of prostate imaging reporting and data system version 2 for detection of prostate cancer: a systematic review and diagnostic meta-analysis. Eur Urol 72:177\u2013188","journal-title":"Eur Urol"},{"issue":"5S","key":"6166_CR24","doi-asserted-by":"publisher","first-page":"620","DOI":"10.6004\/jnccn.2018.0036","volume":"16","author":"PH Carroll","year":"2018","unstructured":"Carroll PH, Mohler JL (2018) NCCN guidelines update: prostate cancer and prostate cancer early detection. J Nat Comp Canc Netw 16(5S):620\u2013623","journal-title":"J Nat Comp Canc Netw"},{"key":"6166_CR25","unstructured":"NICE (2014) Prostate cancer: diagnosis and management. Available via \nhttps:\/\/www.nice.org.uk\/guidance\/cg175\n\n. Accessed on 7 March 2019"},{"key":"6166_CR26","doi-asserted-by":"publisher","first-page":"S79","DOI":"10.1016\/j.purol.2018.08.011","volume":"28","author":"F Rozet","year":"2018","unstructured":"Rozet F, Hennequin C, Beauval JB et al (2018) French ccAFU guidelines - update 2018-2020: prostate cancer. Prog Urol 28:S79\u2013S130","journal-title":"Prog Urol"},{"key":"6166_CR27","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.jclinepi.2017.12.019","volume":"96","author":"JL Donovan","year":"2018","unstructured":"Donovan JL, Young GJ, Walsh EI et al (2018) A prospective cohort and extended comprehensive-cohort design provided insights about the generalizability of a pragmatic trial: the ProtecT prostate cancer trial. J Clin Epidemiol 96:35\u201346","journal-title":"J Clin Epidemiol"},{"key":"6166_CR28","unstructured":"Mambourg F, Jonckheer P, Pi\u00e9rart J, Van Brabandt H (2012) A national clinical practice guideline on the management of localised prostate cancer. Belgian Health Care Knowledge Centre (KCE), KCE reports 194C. \nhttp:\/\/kce.fgov.be\/sites\/default\/files\/page_documents\/KCE_194C_prostate_cancer_0.pdf"},{"issue":"Suppl 1","key":"6166_CR29","doi-asserted-by":"publisher","first-page":"S95","DOI":"10.1016\/S1166-7087(16)30705-9","volume":"27","author":"F Rozet","year":"2016","unstructured":"Rozet F, Hennequin C, Beauval JB et al (2016) CCAFU French national guidelines 2016-2018 on prostate cancer. Prog Urol 27(Suppl 1):S95\u2013S143","journal-title":"Prog Urol"},{"key":"6166_CR30","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1016\/j.eururo.2013.12.012","volume":"66","author":"M de Rooij","year":"2014","unstructured":"de Rooij M, Crienen S, Witjes JA, Barentsz JO, Rovers MM, Grutters JP (2014) Cost-effectiveness of magnetic resonance (MR) imaging and MR-guided targeted biopsy versus systematic transrectal ultrasound-guided biopsy in diagnosing prostate cancer: a modelling study from a health care perspective. Eur Urol 66:430\u2013436","journal-title":"Eur Urol"},{"key":"6166_CR31","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.eururo.2017.08.018","volume":"73","author":"R Faria","year":"2018","unstructured":"Faria R, Soares MO, Spackman E et al (2018) Optimising the diagnosis of prostate cancer in the era of multiparametric magnetic resonance imaging: a cost-effectiveness analysis based on the prostate MR imaging study (PROMIS). Eur Urol 73:23\u201330","journal-title":"Eur Urol"},{"key":"6166_CR32","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1016\/j.eururo.2017.02.026","volume":"72","author":"PC Moldovan","year":"2017","unstructured":"Moldovan PC, Van den Broeck T, Sylvester R et al (2017) What is the negative predictive value of multiparametric magnetic resonance imaging in excluding prostate Cancer at biopsy? A systematic review and meta-analysis from the European Association of Urology Prostate cancer Guidelines Panel. Eur Urol 72:250\u2013266","journal-title":"Eur Urol"},{"key":"6166_CR33","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1016\/S0140-6736(16)32401-1","volume":"389","author":"HU Ahmed","year":"2017","unstructured":"Ahmed HU, El-Shater Bosaily A, Brown LC et al (2017) Diagnostic accuracy of multi-parametric MRI and TRUS biopsy in prostate cancer (PROMIS): a paired validating confirmatory study. Lancet 389:815\u2013822","journal-title":"Lancet"},{"issue":"19","key":"6166_CR34","doi-asserted-by":"publisher","first-page":"1767","DOI":"10.1056\/NEJMoa1801993","volume":"378","author":"Veeru Kasivisvanathan","year":"2018","unstructured":"Kasivisvanathan V, Rannikko AS, Borghi M et al (2018) MRI-targeted or standard biopsy for prostate-cancer diagnosis diagnosis. N Engl J Med. \nhttps:\/\/doi.org\/10.1056\/NEJMoa1801993","journal-title":"New England Journal of Medicine"},{"issue":"4","key":"6166_CR35","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1016\/j.eururo.2018.11.023","volume":"75","author":"Marloes van der Leest","year":"2019","unstructured":"van der Leest M, Cornel E, Isra\u00ebl B et al (2018) Head-to-head comparison of transrectal ultrasound-guided prostate biopsy versus multiparametric prostate resonance imaging with subsequent magnetic resonance-guided biopsy in biopsy-naive men with elevated prostate-specific antigen: a large prospective multicenter clinical study. Eur Urol. \nhttps:\/\/doi.org\/10.1016\/j.eururo.2018.11.023","journal-title":"European Urology"},{"key":"6166_CR36","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1016\/j.eururo.2013.03.030","volume":"64","author":"CM Moore","year":"2013","unstructured":"Moore CM, Kasivisvanathan V, Eggener S et al (2013) Standards of reporting for MRI-targeted biopsy studies (START) of the prostate: recommendations from an International Working Group. Eur Urol 64:544\u2013552","journal-title":"Eur Urol"},{"issue":"3","key":"6166_CR37","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1016\/j.eururo.2017.02.021","volume":"73","author":"Wulphert Venderink","year":"2018","unstructured":"Venderink W, van Luijtelaar A, Bomers JG et al (2017) Results of targeted biopsy in men with magnetic resonance imaging lesions classified equivocal, likely or highly likely to be clinically significant prostate cancer. Eur Urol. \nhttps:\/\/doi.org\/10.1016\/j.eururo.2017.02.021","journal-title":"European Urology"},{"issue":"1","key":"6166_CR38","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.eururo.2018.03.007","volume":"74","author":"Valeria Panebianco","year":"2018","unstructured":"Panebianco V, Barchetti G, Simone G et al (2018) Negative multiparametric magnetic resonance imaging for prostate cancer: what\u2019s next? Eur Urol. \nhttps:\/\/doi.org\/10.1016\/j.eururo.2018.03.007","journal-title":"European Urology"},{"key":"6166_CR39","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1016\/j.eururo.2014.08.077","volume":"67","author":"E Baco","year":"2015","unstructured":"Baco E, Ukimura O, Rud E et al (2015) Magnetic resonance imaging-transectal ultrasound image-fusion biopsies accurately characterize the index tumor: correlation with step-sectioned radical prostatectomy specimens in 135 patients. Eur Urol 67:787\u2013794","journal-title":"Eur Urol"},{"issue":"4","key":"6166_CR40","doi-asserted-by":"publisher","first-page":"1198","DOI":"10.1016\/j.juro.2014.11.002","volume":"193","author":"Nicolas Barry Delongchamps","year":"2015","unstructured":"Delongchamps NB, Lefevre A, Bouazza N, Beuvon F, Legman P, Cornud F (2014) Detection of significant prostate cancer with magnetic resonance targeted biopsies-should transrectal ultrasound-magnetic resonance imaging fusion guided biopsies alone be a standard of care? J Urol. \nhttps:\/\/doi.org\/10.1016\/j.juro.2014.11.002","journal-title":"Journal of Urology"},{"key":"6166_CR41","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.juro.2015.07.080","volume":"195","author":"DN Costa","year":"2016","unstructured":"Costa DN, Lotan Y, Rofsky NM et al (2016) Assessment of prospectively assigned Likert scores for targeted magnetic resonance imaging-transrectal ultrasound fusion biopsies in patients with suspected prostate cancer. J Urol 195:80\u201387","journal-title":"J Urol"},{"key":"6166_CR42","doi-asserted-by":"publisher","first-page":"e120","DOI":"10.1016\/j.crad.2013.10.018","volume":"69","author":"H Habchi","year":"2014","unstructured":"Habchi H, Bratan F, Paye A et al (2014) Value of prostate multiparametric magnetic resonance imaging for predicting biopsy results in first or repeat biopsy. Clin Radiol 69:e120\u2013e128","journal-title":"Clin Radiol"},{"key":"6166_CR43","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1111\/bju.12690","volume":"115","author":"P Mozer","year":"2015","unstructured":"Mozer P, Roupr\u00eat M, Le Cossec C et al (2015) First round of targeted biopsies using magnetic resonance imaging\/ultrasonography fusion compared with conventional transrectal ultrasonography-guided biopsies for the diagnosis of localised prostate cancer. BJU Int 115:50\u201357","journal-title":"BJU Int"},{"key":"6166_CR44","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1007\/s00345-015-1671-8","volume":"34","author":"H Cash","year":"2016","unstructured":"Cash H, Maxeiner A, Stephan C et al (2016) The detection of significant prostate cancer is correlated with the prostate imaging reporting and data system (PI-RADS) in MRI\/transrectal ultrasound fusion biopsy. World J Urol 34:525\u2013532","journal-title":"World J Urol"},{"key":"6166_CR45","doi-asserted-by":"publisher","first-page":"2582","DOI":"10.1007\/s00330-014-3276-9","volume":"24","author":"L Schimm\u00f6ller","year":"2014","unstructured":"Schimm\u00f6ller L, Quentin M, Arsov C et al (2014) MR-sequences for prostate cancer diagnostics: validation based on the PI-RADS scoring system and targeted MR-guided in-bore biopsy. Eur Radiol 24:2582\u20132589","journal-title":"Eur Radiol"},{"key":"6166_CR46","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1016\/j.juro.2016.04.057","volume":"196","author":"FV Mertan","year":"2016","unstructured":"Mertan FV, Greer MD, Shih JH et al (2016) Prospective evaluation of the prostate imaging reporting and data system version 2 for prostate cancer detection. J Urol 196:690\u2013696","journal-title":"J Urol"},{"key":"6166_CR47","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.eururo.2014.10.026","volume":"68","author":"M Valerio","year":"2015","unstructured":"Valerio M, Donaldson I, Emberton M et al (2015) Detection of clinically significant prostate cancer using magnetic resonance imaging-ultrasound fusion targeted biopsy: a systematic review. Eur Urol 68:8\u201319","journal-title":"Eur Urol"},{"key":"6166_CR48","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1016\/j.eururo.2014.11.037","volume":"68","author":"IG Schoots","year":"2015","unstructured":"Schoots IG, Roobol MJ, Nieboer D, Bangma CH, Steyerberg EW, Hunink MG (2015) Magnetic resonance imaging-targeted biopsy may enhance the diagnostic accuracy of significant prostate cancer detection compared to standard transrectal ultrasound-guided biopsy: a systematic review and meta-analysis. Eur Urol 68:438\u2013450","journal-title":"Eur Urol"},{"key":"6166_CR49","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1016\/j.eururo.2016.12.006","volume":"71","author":"MG Schouten","year":"2017","unstructured":"Schouten MG, van der Leest M, Pokorny M et al (2017) Why and where do we miss significant prostate cancer with multi-parametric magnetic resonance imaging followed by magnetic resonance-guided and Transrectal ultrasound-guided biopsy in biopsy-naive men? Eur Urol 71:896\u2013903","journal-title":"Eur Urol"},{"key":"6166_CR50","doi-asserted-by":"publisher","first-page":"1098","DOI":"10.1007\/s00330-015-3894-x","volume":"26","author":"PJ De Visschere","year":"2016","unstructured":"De Visschere PJ, Naesens L, Libbrecht L et al (2016) What kind of prostate cancers do we miss on multiparametric magnetic resonance imaging? Eur Radiol 26:1098\u20131107","journal-title":"Eur Radiol"},{"key":"6166_CR51","doi-asserted-by":"publisher","first-page":"E171","DOI":"10.1111\/j.1464-410X.2011.10112.x","volume":"108","author":"J Haffner","year":"2011","unstructured":"Haffner J, Lemaitre L, Puech P et al (2011) Role of magnetic resonance imaging before initial biopsy: comparison of magnetic resonance imaging-targeted and systematic biopsy for significant prostate cancer detection. BJU Int 108:E171\u2013E178","journal-title":"BJU Int"},{"key":"6166_CR52","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.eururo.2012.06.004","volume":"63","author":"CM Moore","year":"2013","unstructured":"Moore CM, Robertson NL, Arsanious N et al (2013) Image-guided prostate biopsy using magnetic resonance imaging-derived targets: a systematic review. Eur Urol 63:125\u2013140","journal-title":"Eur Urol"},{"key":"6166_CR53","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1001\/jama.2014.17942","volume":"313","author":"MM Siddiqui","year":"2015","unstructured":"Siddiqui MM, Rais-Bahrami S, Turkbey B et al (2015) Comparison of MR\/ultrasound fusion-guided biopsy with ultrasound-guided biopsy for the diagnosis of prostate cancer. JAMA 313:390\u2013397","journal-title":"JAMA"},{"key":"6166_CR54","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/S1470-2045(18)30569-2","volume":"20","author":"O Rouvi\u00e8re","year":"2019","unstructured":"Rouvi\u00e8re O, Puech P, Renard-Penna R et al (2019) Use of prostate systematic and targeted biopsy on the basis of multiparametric MRI in biopsy-naive patients (MRI-FIRST): a prospective, multicentre, paired diagnostic study. Lancet Oncol 20:100\u2013109","journal-title":"Lancet Oncol"},{"key":"6166_CR55","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.euo.2018.03.009","volume":"1","author":"N Patel","year":"2018","unstructured":"Patel N, Cricco-Lizza E, Kasabwala K et al (2018) The role of systematic and targeted biopsies in light of overlap on magnetic resonance imaging ultrasound fusion biopsy. Eur Urol Oncol 1:263\u2013267","journal-title":"Eur Urol Oncol"},{"key":"6166_CR56","doi-asserted-by":"publisher","first-page":"888","DOI":"10.1016\/j.eururo.2017.03.039","volume":"72","author":"JP Radtke","year":"2017","unstructured":"Radtke JP, Wiesenfarth M, Kesch C et al (2017) Combined clinical parameters and multiparametric magnetic resonance imaging for advanced risk modeling of prostate cancer-patient-tailored risk stratification can reduce unnecessary biopsies. Eur Urol 72:888\u2013896","journal-title":"Eur Urol"},{"key":"6166_CR57","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1016\/j.juro.2017.03.130","volume":"198","author":"FA Distler","year":"2017","unstructured":"Distler FA, Radtke JP, Bonekamp D et al (2017) The value of PSA density in combination with PI-RADS for the accuracy of prostate cancer prediction. J Urol 198:575\u2013582","journal-title":"J Urol"},{"key":"6166_CR58","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1001\/jamaoncol.2017.5667","volume":"4","author":"S Mehralivand","year":"2018","unstructured":"Mehralivand S, Shih JH, Rais-Bahrami S et al (2018) A magnetic resonance imaging-based prediction model for prostate biopsy risk stratification. JAMA Oncol 4:678\u2013685","journal-title":"JAMA Oncol"},{"key":"6166_CR59","doi-asserted-by":"publisher","first-page":"70","DOI":"10.21037\/tau.2017.12.31","volume":"7","author":"IG Schoots","year":"2018","unstructured":"Schoots IG (2018) MRI in early prostate cancer detection: how to manage indeterminate or equivocal PI-RADS 3 lesions? Transl Androl Urol 7:70\u201382","journal-title":"Transl Androl Urol"},{"key":"6166_CR60","doi-asserted-by":"publisher","first-page":"1272","DOI":"10.2214\/AJR.17.18008","volume":"209","author":"ER Felker","year":"2017","unstructured":"Felker ER, Raman SS, Margolis DJ et al (2017) Risk stratification among men with prostate imaging reporting and data system version 2 category 3 transition zone lesions: is biopsy always necessary? AJR Am J Roentgenol 209:1272\u20131277","journal-title":"AJR Am J Roentgenol"},{"key":"6166_CR61","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/s12880-017-0184-x","volume":"17","author":"XK Niu","year":"2017","unstructured":"Niu XK, Li J, Das SK, Xiong Y, Yang CB, Peng T (2017) Developing a nomogram based on multiparametric magnetic resonance imaging for forecasting high-grade prostate cancer to reduce unnecessary biopsies within the prostate-specific antigen gray zone. BMC Med Imaging 17:11","journal-title":"BMC Med Imaging"},{"key":"6166_CR62","doi-asserted-by":"publisher","first-page":"1315","DOI":"10.1111\/j.1464-410X.2011.10612.x","volume":"109","author":"A Shukla-Dave","year":"2012","unstructured":"Shukla-Dave A, Hricak H, Akin O et al (2012) Preoperative nomograms incorporating magnetic resonance imaging and spectroscopy for prediction of insignificant prostate cancer. BJU Int 109:1315\u20131322","journal-title":"BJU Int"},{"key":"6166_CR63","doi-asserted-by":"publisher","first-page":"W715","DOI":"10.2214\/AJR.10.5700","volume":"196","author":"JC Vilanova","year":"2011","unstructured":"Vilanova JC, Barcel\u00f3-Vidal C, Comet J et al (2011) Usefulness of prebiopsy multifunctional and morphologic MRI combined with free-to-total prostate-specific antigen ratio in the detection of prostate cancer. AJR Am J Roentgenol 196:W715\u2013W722","journal-title":"AJR Am J Roentgenol"},{"key":"6166_CR64","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1111\/bju.13619","volume":"119","author":"NL Hansen","year":"2017","unstructured":"Hansen NL, Barrett T, Koo B et al (2017) The influence of prostate-specific antigen density on positive and negative predictive values of multiparametric magnetic resonance imaging to detect Gleason score 7-10 prostate cancer in a repeat biopsy setting. BJU Int 119:724\u2013730","journal-title":"BJU Int"},{"key":"6166_CR65","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1111\/bju.13465","volume":"119","author":"S Washino","year":"2017","unstructured":"Washino S, Okochi T, Saito K et al (2017) Combination of prostate imaging reporting and data system (PI-RADS) score and prostate-specific antigen (PSA) density predicts biopsy outcome in prostate biopsy naive patients. BJU Int 119:225\u2013233","journal-title":"BJU Int"},{"key":"6166_CR66","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1159\/000365697","volume":"8","author":"H Liddell","year":"2015","unstructured":"Liddell H, Jyoti R, Haxhimolla HZ (2015) mp-MRI prostate characterised PIRADS 3 lesions are associated with a low risk of clinically significant prostate cancer - a retrospective review of 92 biopsied PIRADS 3 lesions. Curr Urol 8:96\u2013100","journal-title":"Curr Urol"},{"key":"6166_CR67","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1111\/bju.14049","volume":"122","author":"NL Hansen","year":"2018","unstructured":"Hansen NL, Barrett T, Kesch C et al (2018) Multicentre evaluation of magnetic resonance imaging supported transperineal prostate biopsy in biopsy-naive men with suspicion of prostate cancer. BJU Int 122:40\u201349","journal-title":"BJU Int"},{"key":"6166_CR68","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1038\/pcan.2013.43","volume":"17","author":"M Abd-Alazeez","year":"2014","unstructured":"Abd-Alazeez M, Kirkham A, Ahmed HU et al (2014) Performance of multiparametric MRI in men at risk of prostate cancer before the first biopsy: a paired validating cohort study using template prostate mapping biopsies as the reference standard. Prostate Cancer Prostatic Dis 17:40\u201346","journal-title":"Prostate Cancer Prostatic Dis"},{"key":"6166_CR69","first-page":"1087","volume":"32","author":"C Arsov","year":"2012","unstructured":"Arsov C, Quentin M, Rabenalt R, Antoch G, Albers P, Blondin D (2012) Repeat transrectal ultrasound biopsies with additional targeted cores according to results of functional prostate MRI detects high-risk prostate cancer in patients with previous negative biopsy and increased PSA - a pilot study. Anticancer Res 32:1087\u20131092","journal-title":"Anticancer Res"},{"key":"6166_CR70","doi-asserted-by":"publisher","first-page":"343","DOI":"10.2214\/AJR.13.11046","volume":"202","author":"M de Rooij","year":"2014","unstructured":"de Rooij M, Hamoen EH, F\u00fctterer JJ, Barentsz JO, Rovers MM (2014) Accuracy of multiparametric MRI for prostate cancer detection: a meta-analysis. AJR Am J Roentgenol 202:343\u2013351","journal-title":"AJR Am J Roentgenol"},{"issue":"5","key":"6166_CR71","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1111\/bju.12862","volume":"115","author":"Alistair D.R. Grey","year":"2014","unstructured":"Grey AD, Chana MS, Popert R, Wolfe K, Liyanage SH, Acher PL (2014) Diagnostic accuracy of magnetic resonance imaging (MRI) prostate imaging reporting and data system (PI-RADS) scoring in a transperineal prostate biopsy setting. BJU Int. \nhttps:\/\/doi.org\/10.1111\/bju.12862","journal-title":"BJU International"},{"key":"6166_CR72","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.eururo.2014.03.002","volume":"66","author":"MR Pokorny","year":"2014","unstructured":"Pokorny MR, de Rooij M, Duncan E et al (2014) Prospective study of diagnostic accuracy comparing prostate cancer detection by transrectal ultrasound-guided biopsy versus magnetic resonance (MR) imaging with subsequent MR-guided biopsy in men without previous prostate biopsies. Eur Urol 66:22\u201329","journal-title":"Eur Urol"},{"key":"6166_CR73","doi-asserted-by":"publisher","first-page":"986","DOI":"10.1016\/j.eururo.2012.06.044","volume":"62","author":"D Portalez","year":"2012","unstructured":"Portalez D, Mozer P, Cornud F et al (2012) Validation of the European Society of Urogenital Radiology scoring system for prostate cancer diagnosis on multiparametric magnetic resonance imaging in a cohort of repeat biopsy patients. Eur Urol 62:986\u2013996","journal-title":"Eur Urol"},{"issue":"8","key":"6166_CR74","doi-asserted-by":"publisher","first-page":"1430","DOI":"10.1016\/j.urolonc.2012.02.018","volume":"31","author":"Andrew B. Rosenkrantz","year":"2013","unstructured":"Rosenkrantz AB, Mussi TC, Borofsky MS, Scionti SS, Grasso M, Taneja SS (2012) 3.0 T multiparametric prostate MRI using pelvic phased-array coil: utility for tumor detection prior to biopsy. Urol Oncol. \nhttps:\/\/doi.org\/10.1016\/j.urolonc.2012.02.018","journal-title":"Urologic Oncology: Seminars and Original Investigations"},{"key":"6166_CR75","doi-asserted-by":"publisher","first-page":"1732","DOI":"10.1016\/j.juro.2012.07.024","volume":"188","author":"HA Vargas","year":"2012","unstructured":"Vargas HA, Akin O, Afaq A et al (2012) Magnetic resonance imaging for predicting prostate biopsy findings in patients considered for active surveillance of clinically low risk prostate cancer. J Urol 188:1732\u20131738","journal-title":"J Urol"},{"key":"6166_CR76","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1148\/radiol.13122233","volume":"269","author":"AB Rosenkrantz","year":"2013","unstructured":"Rosenkrantz AB, Kim S, Lim RP et al (2013) Prostate cancer localization using multiparametric MR imaging: comparison of prostate imaging reporting and data system (PI-RADS) and Likert scales. Radiology 269:482\u2013492","journal-title":"Radiology"},{"key":"6166_CR77","doi-asserted-by":"publisher","first-page":"W612","DOI":"10.2214\/AJR.12.10173","volume":"201","author":"AB Rosenkrantz","year":"2013","unstructured":"Rosenkrantz AB, Lim RP, Haghighi M, Somberg MB, Babb JS, Taneja SS (2013) Comparison of interreader reproducibility of the prostate imaging reporting and data system and likert scales for evaluation of multiparametric prostate MRI. AJR Am J Roentgenol 201:W612\u2013W618","journal-title":"AJR Am J Roentgenol"},{"key":"6166_CR78","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1148\/radiol.14131584","volume":"272","author":"T Vach\u00e9","year":"2014","unstructured":"Vach\u00e9 T, Bratan F, M\u00e8ge-Lechevallier F, Roche S, Rabilloud M, Rouvi\u00e8re O (2014) Characterization of prostate lesions as benign or malignant at multiparametric MR imaging: comparison of three scoring systems in patients treated with radical prostatectomy. Radiology 272:446\u2013455","journal-title":"Radiology"},{"key":"6166_CR79","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.juro.2014.01.014","volume":"192","author":"JE Thompson","year":"2014","unstructured":"Thompson JE, Moses D, Shnier R et al (2014) Multiparametric magnetic resonance imaging guided diagnostic biopsy detects significant prostate cancer and could reduce unnecessary biopsies and over detection: a prospective study. J Urol 192:67\u201374","journal-title":"J Urol"},{"key":"6166_CR80","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1148\/radiol.14140184","volume":"275","author":"R Renard-Penna","year":"2015","unstructured":"Renard-Penna R, Mozer P, Cornud F et al (2015) Prostate imaging reporting and data system and Likert scoring system: multiparametric MR imaging validation study to screen patients for initial biopsy. Radiology 275:458\u2013468","journal-title":"Radiology"},{"key":"6166_CR81","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1148\/radiol.2015142818","volume":"277","author":"BG Muller","year":"2015","unstructured":"Muller BG, Shih JH, Sankineni S et al (2015) Prostate cancer: interobserver agreement and accuracy with the revised prostate imaging reporting and data system at multiparametric MR imaging. Radiology 277:741\u2013750","journal-title":"Radiology"},{"key":"6166_CR82","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1016\/j.ejrad.2016.01.011","volume":"85","author":"M Kasel-Seibert","year":"2016","unstructured":"Kasel-Seibert M, Lehmann T, Aschenbach R et al (2016) Assessment of PI-RADS v2 for the detection of prostate cancer. Eur J Radiol 85:726\u2013731","journal-title":"Eur J Radiol"},{"key":"6166_CR83","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1016\/j.clinimag.2016.04.010","volume":"40","author":"C Zhao","year":"2016","unstructured":"Zhao C, Gao G, Fang D et al (2016) The efficiency of multiparametric magnetic resonance imaging (mpMRI) using PI-RADS version 2 in the diagnosis of clinically significant prostate cancer. Clin Imaging 40:885\u2013888","journal-title":"Clin Imaging"},{"key":"6166_CR84","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1148\/radiol.2016152542","volume":"280","author":"AB Rosenkrantz","year":"2016","unstructured":"Rosenkrantz AB, Ginocchio LA, Cornfeld D et al (2016) Interobserver reproducibility of the PI-RADS version 2 lexicon: a multicenter study of six experienced prostate radiologists. Radiology 280:793\u2013804","journal-title":"Radiology"},{"key":"6166_CR85","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.1016\/j.ejrad.2016.03.025","volume":"85","author":"S Polanec","year":"2016","unstructured":"Polanec S, Helbich TH, Bickel H et al (2016) Head-to-head comparison of PI-RADS v2 and PI-RADS v1. Eur J Radiol 85:1125\u20131131","journal-title":"Eur J Radiol"},{"key":"6166_CR86","doi-asserted-by":"publisher","first-page":"e0162879","DOI":"10.1371\/journal.pone.0162879","volume":"11","author":"S Tewes","year":"2016","unstructured":"Tewes S, Mokov N, Hartung D et al (2016) Standardized reporting of prostate MRI: comparison of the prostate imaging reporting and data system (PI-RADS) version 1 and version 2. PLoS One 11:e0162879","journal-title":"PLoS One"},{"key":"6166_CR87","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1002\/jmri.25372","volume":"45","author":"MD Greer","year":"2017","unstructured":"Greer MD, Brown AM, Shih JH et al (2017) Accuracy and agreement of PIRADSv2 for prostate cancer mpMRI: a multireader study. J Magn Reson Imaging 45:579\u2013585","journal-title":"J Magn Reson Imaging"},{"key":"6166_CR88","doi-asserted-by":"publisher","first-page":"2259","DOI":"10.1007\/s00330-016-4635-5","volume":"27","author":"NL Hansen","year":"2017","unstructured":"Hansen NL, Koo BC, Gallagher FA et al (2017) Comparison of initial and tertiary centre second opinion reads of multiparametric magnetic resonance imaging of the prostate prior to repeat biopsy. Eur Radiol 27:2259\u20132266","journal-title":"Eur Radiol"}],"container-title":["European Radiology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00330-019-06166-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00330-019-06166-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00330-019-06166-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,6,4]],"date-time":"2020-06-04T19:34:20Z","timestamp":1591299260000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00330-019-06166-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6,6]]},"references-count":88,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["6166"],"URL":"https:\/\/doi.org\/10.1007\/s00330-019-06166-z","relation":{},"ISSN":["0938-7994","1432-1084"],"issn-type":[{"value":"0938-7994","type":"print"},{"value":"1432-1084","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,6,6]]},"assertion":[{"value":"15 November 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 March 2019","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 March 2019","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 June 2019","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The scientific guarantor of this publication is Jonathan Richenberg, MA BM Bch MRCP FRCR Hon Sen Lect BSMS, on behalf of ESUR Prostate Working Group.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Guarantor"}},{"value":"The authors of this manuscript declare no relationships with any companies, whose products or services may be related to the subject matter of the article.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"No complex statistical methods were necessary for this paper.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Statistics and biometry"}},{"value":"No human subjects involved.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"Institutional Review Board approval was not required because this is a review article of evidence published.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"\u2022 Literature review and evidence analysis.\u2022 Multicentre study\u2014ESUR Working Group, Prostate Cancer with representatives from the UK, France, Denmark, Italy, and Netherlands","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Methodology"}}]}}